Patents by Inventor Egon Persson

Egon Persson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Factor VII Fusion Polypeptides
    Publication number: 20120321607
    Abstract: The present invention relates to a Factor VII (FVII) fusion polypeptide with a prolonged half-life, wherein the FVII polypeptide can be activated or is in the activated form.
    Type: Application
    Filed: January 27, 2011
    Publication date: December 20, 2012
    Applicant: Novo Nordisk Health Care AG
    Inventor: Egon Persson
  • Method for the production of proteins
    Patent number: 8084587
    Abstract: The present invention relates to a process for the purification of a protease.
    Type: Grant
    Filed: January 26, 2010
    Date of Patent: December 27, 2011
    Assignee: Novo Nordisk Health Care AG
    Inventors: Janus Krarup, Egon Persson
  • Method for the Production of Proteins
    Publication number: 20110081702
    Abstract: The present invention relates to a process for the purification of a protease.
    Type: Application
    Filed: December 20, 2010
    Publication date: April 7, 2011
    Applicant: Novo Nordisk HealthCare A/G
    Inventors: Janus Krarup, Egon Persson
  • Coagulation Factor VII Polypeptides
    Publication number: 20100197597
    Abstract: The present invention relates to novel coagulation Factor VII polypeptides, polynucleotide constructs encoding such polypeptides, as well as vectors and host cells comprising and expressing the polynucleotide, pharmaceutical compositions, uses and methods of treatment.
    Type: Application
    Filed: April 19, 2010
    Publication date: August 5, 2010
    Applicant: Novo Nordisk HealthCare A/G
    Inventors: Henrik Østergaard, Søren Bjørn, Egon Persson
  • Human Coagulation Factor VII Variants
    Publication number: 20100158891
    Abstract: The present invention encompasses isolated human coagulation Factor VII variants comprising a substitution of Phe in position 374 of SEQ ID NO 1 with another amino acid residue.
    Type: Application
    Filed: January 18, 2010
    Publication date: June 24, 2010
    Applicant: NOVO NORDISK HEALTHCARE A/G
    Inventors: EGON PERSSON, OLE HVILSTED OLSEN
  • Method for the Production of Proteins
    Publication number: 20100136622
    Abstract: The present invention relates to a process for the purification of a protease.
    Type: Application
    Filed: January 26, 2010
    Publication date: June 3, 2010
    Applicant: Novo Nordisk HealthCare A/G
    Inventors: Janus Krarup, Egon Persson
  • Nucleic acids encoding human coagulation FVII polypeptides
    Patent number: 7695935
    Abstract: The present invention relates to novel human coagulation Factor VIIa variants having coagulant activity as well as nucleic acid constructs encoding such variants, vectors and host cells comprising and expressing the nucleic acid, pharmaceutical compositions, uses and methods of treatment.
    Type: Grant
    Filed: July 14, 2006
    Date of Patent: April 13, 2010
    Assignee: Novo Nordisk Healthcare A/G
    Inventors: Egon Persson, Ole Hvilsted Olsen
  • N-Terminal Pegylated Prolactin Receptor Molecules
    Publication number: 20100035814
    Abstract: The invention is concerned with N-terminally pegylated polypeptides capable of binding to the prolactin receptor. Such polypeptides may for instance be N-terminally pegylated antagonists of the prolactin receptor, such as for instance prolactin variants.
    Type: Application
    Filed: November 9, 2007
    Publication date: February 11, 2010
    Applicant: Novo Nordisk A/S
    Inventors: Bernd Peschke, Leif Christensen, Egon Persson
  • Human Coagulation Factor VII Polypeptides
    Publication number: 20090104661
    Abstract: The present invention relates to novel human coagulation Factor VIIa variants having coagulant activity as well as polynucleotide constructs encoding such variants, vectors and host cells comprising and expressing the polynucleotide, pharmaceutical compositions, uses and methods of treatment.
    Type: Application
    Filed: July 7, 2008
    Publication date: April 23, 2009
    Applicant: Novo Nordisk A/S
    Inventors: Egon Persson, Ole Hvilsted Olsen
  • Human Coagulation Factor VII Polypeptides
    Publication number: 20090011992
    Abstract: The present invention relates to novel human coagulation Factor VIIa variants having coagulant activity as well as polynucleotide constructs encoding such variants, vectors and host cells comprising and expressing the polynucleotide, pharmaceutical compositions, uses and methods of treatment.
    Type: Application
    Filed: September 21, 2006
    Publication date: January 8, 2009
    Applicant: Novo Nordisk HealthCare A/G
    Inventors: Ole Hvilsted Olsen, Jais Rose Bjelke, Egon Persson
  • Human Coagulation Factor VII Variants
    Publication number: 20080318276
    Abstract: The invention concerns novel coagulation factor VII variants, wherein the Phe residue in position 374 of SEQ ID NO 1 has been replaced by another amino acid residue which can be encoded by nucleic acid constructs and, optionally, wherein at least one other amino acid residue in the remaining positions in the protease domain has been replaced by another amino acid residue which can be encoded by nucleic acid constructs; with the proviso that the variant is not FVII(Ala305).
    Type: Application
    Filed: July 23, 2008
    Publication date: December 25, 2008
    Applicant: Novo Nordisk HealthCare A/G
    Inventors: Egon Persson, Ole Hvilsted Olsen
  • Nucleic acids encoding human coagulation Factor VII polypeptides
    Patent number: 7419803
    Abstract: The present invention relates to novel human coagulation Factor VIIa variants having coagulant activity as well as polynucleotide constructs encoding such variants, vectors and host cells comprising and expressing the polynucleotide, pharmaceutical compositions, uses and methods of treatment.
    Type: Grant
    Filed: March 24, 2005
    Date of Patent: September 2, 2008
    Assignee: Novo Nordisk A/S
    Inventors: Egon Persson, Ole Hvilsted Olsen
  • Nucleic acids encoding human coagulation factor VII variants
    Patent number: 7416860
    Abstract: The invention concerns nucleic acids encoding coagulation Factor VII variants in which the Leu residue in position 305 has been replaced by another amino acid residue. The invention further concerns the expression of such nucleic acids resulting in a Factor VII variant having increased biological activity.
    Type: Grant
    Filed: April 21, 2005
    Date of Patent: August 26, 2008
    Assignee: Novo Nordisk HelathCare A/G
    Inventors: Egon Persson, Ole Hvilsted Olsen
  • Human coagulation factor VII polypeptides
    Patent number: 7416861
    Abstract: The present invention relates to novel human coagulation Factor VIIa variants having coagulant activity as well as polynucleotide constructs encoding such variants, vectors and host cells comprising and expressing the polynucleotide, pharmaceutical compositions, uses and methods of treatment.
    Type: Grant
    Filed: April 21, 2005
    Date of Patent: August 26, 2008
    Assignee: Novo Nordisk Healthcare A/G
    Inventors: Egon Persson, Ole Hvilsted Olsen
  • Human coagulation factor VII polypeptides
    Publication number: 20080010693
    Abstract: The present invention relates to novel human coagulation Factor VIIa variants having coagulant activity as well as polynucleotide constructs encoding such variants, vectors and host cells comprising and expressing the polynucleotide, pharmaceutical compositions, uses and methods of treatment.
    Type: Application
    Filed: April 21, 2005
    Publication date: January 10, 2008
    Applicant: Novo Nordisk HealthCare A/G
    Inventors: Egon Persson, Ole Olsen
  • Coagulation factor VII derivatives
    Patent number: 7235638
    Abstract: The present invention relates to novel human coagulation Factor VII polypeptides, Factor VII derivatives as well as polynucleotide constructs encoding such polypeptides, vectors and host cells comprising and expressing the polynucleotide, pharmaceutical compositions, uses and methods of treatment.
    Type: Grant
    Filed: March 22, 2002
    Date of Patent: June 26, 2007
    Assignee: Novo Nordisk HealthCare A/G
    Inventor: Egon Persson
  • Novel compounds
    Publication number: 20070037746
    Abstract: The present invention relates to novel coagulation factor FVIIa polypeptides.
    Type: Application
    Filed: August 1, 2006
    Publication date: February 15, 2007
    Applicant: Novo Nordisk HealthCare A/G
    Inventors: Henrik Ostergaard, Egon Persson
  • Human coagulation factor VII variants
    Patent number: 7176288
    Abstract: The present invention relates to novel human coagulation Factor VIIa variants having coagulant activity as well as nucleic acid constructs encoding such variants, vectors and host cells comprising and expressing the nucleic acid, pharmaceutical compositions, uses and methods of treatment.
    Type: Grant
    Filed: September 13, 2001
    Date of Patent: February 13, 2007
    Assignee: Novo Nordisk HealthCare A/G
    Inventors: Egon Persson, Ole Hvilsted Olsen
  • Human coagulation Factor VII variants
    Publication number: 20060252129
    Abstract: The present invention relates to novel human coagulation Factor VIIa variants having coagulant activity as well as nucleic acid constructs encoding such variants, vectors and host cells comprising and expressing the nucleic acid, pharmaceutical compositions, uses and methods of treatment.
    Type: Application
    Filed: July 14, 2006
    Publication date: November 9, 2006
    Applicant: Novo Nordisk HealthCare A/G
    Inventors: Egon Persson, Ole Olsen
  • Coagulation Factor VII polypeptides
    Publication number: 20060205036
    Abstract: The present invention relates to novel coagulation Factor VII polypeptides, polynucleotide constructs encoding such polypeptides, as well as vectors and host cells comprising and expressing the polynucleotide, pharmaceutical compositions, uses and methods of treatment.
    Type: Application
    Filed: March 3, 2006
    Publication date: September 14, 2006
    Applicant: Novo Nordisk HealthCare A/G
    Inventors: Henrik Ostergaard, Soren Bjorn, Egon Persson